BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25731255)

  • 1. [A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].
    Kitahara T; Takemasa I; Inoue A; Osawa H; Miyo M; Mokutani Y; Ogawa H; Naito A; Hamabe A; Hiraki M; Munakata K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1569-71. PubMed ID: 25731255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
    Miyazawa T; Ebe K; Fujita N; Koide N; Honma K; Ikarashi T
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):1001-3. PubMed ID: 22705702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.
    Hasegawa J; Nishimura J; Mizushima T; Miyake Y; Kim HM; Takemoto H; Tamagawa H; Noura S; Fujii M; Fujie Y; Kato T; Miwa H; Takemasa I; Ikeda M; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M
    Cancer Chemother Pharmacol; 2014 May; 73(5):1079-87. PubMed ID: 24595805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Feasibility Study of Neoadjuvant XELOX Without Radiotherapy for Locally Advanced Lower Rectal Cancer.
    Ueki T; Manabe T; Inoue S; Ienaga J; Yamanaka N; Egami T; Ishikawa M; Konomi H; Ikubo A; Nagayoshi K; Nakamura M; Tanaka M
    Anticancer Res; 2016 Feb; 36(2):741-7. PubMed ID: 26851033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of pathological complete response with neoadjuvant mFOLFOX6 chemotherapy for advanced lower rectal cancer].
    Sueda T; Noura S; Ohue M; Shingai T; Gotoh K; Motoori M; Takahashi H; Kishi K; Marubashi S; Fujiwara Y; Ohigashi H; Yano M; Tomita Y; Ishikawa O
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1965-7. PubMed ID: 24393981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant chemoradiotherapy with capecitabine and oxaliplatin for the treatment of locally advanced lower rectal cancer].
    Murata K; Okamura S; Okubo H; Owada Y; Nishigaki T; Wada Y; Kato R; Makino S; Takeoka T; Okada K; Fukuchi N; Ebisui C; Kinuta M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2020-2. PubMed ID: 24393999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of locally advanced rectal cancer had a pathological complete response to XELOX Therapy].
    Tonoike Y; Kawahara M; Makino S; Nishimura A; Kawachi Y; Nikkuni K; Sato A; Fukuhara Y; Watanabe S; Sato T; Tomidokoro T; Ikarashi T
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):683-6. PubMed ID: 22504703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer: a prospective phase 2 trial.
    Gao YH; Lin JZ; An X; Luo JL; Cai MY; Cai PQ; Kong LH; Liu GC; Tang JH; Chen G; Pan ZZ; Ding PR
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1153-60. PubMed ID: 25442042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
    Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S
    Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of neoadjuvant chemotherapy for locally advanced rectal cancer, which had a invasion into the vagina followed by curative resection].
    Kimura K; Kagawa Y; Kato T; Ishida T; Morimoto Y; Matusita K; Kusama H; Hashimoto T; Katura Y; Nitta K; Takeno A; Nakahira S; Okishiro M; Sakisaka H; Taniguchi H; Egawa C; Takeda Y; Tamura S
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1740-2. PubMed ID: 25731314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study.
    Kamiya T; Uehara K; Nakayama G; Ishigure K; Kobayashi S; Hiramatsu K; Nakayama H; Yamashita K; Sakamoto E; Tojima Y; Kawai S; Kodera Y; Nagino M;
    Eur J Surg Oncol; 2016 Jun; 42(6):829-35. PubMed ID: 26968228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of advanced rectal cancer resected successfully after preoperative XELOX chemotherapy].
    Yagi Y; Iiai T; Saitou K; Kameyama H; Nogami H; Umezu H; Hatakeyama K
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1221-4. PubMed ID: 21772117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Pathological Complete Response after Neoadjuvant Chemotherapy(S-1 plus Oxaliplatin)and Laparoscopic Low Anterior Resection for Rectal Cancer].
    Ichinohe D; Morohashi H; Umetsu S; Yoshida T; Wakasa Y; Odagiri T; Kimura T; Suto A; Saito T; Yoshida E; Akasaka H; Jin H; Miura T; Sakamoto Y; Hakamada K
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1715-1717. PubMed ID: 28133108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.
    Soumarova R; Skrovina M; Bartos J; Gruna J; Wendrinski A; Czudek S; Kycina R; Parvez J
    Eur J Surg Oncol; 2010 Mar; 36(3):251-6. PubMed ID: 19879716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of rectal endocrine cell carcinoma treated by laparoscopic assisted intersphincteric resection after neoadjuvant chemotherapy].
    Wakatsuki K; Yoshioka S; Shiobara M; Kataoka M; Arai S; Tonooka T; Miyazawa K; Oeda Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2026-8. PubMed ID: 24394001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of advanced rectal cancer that showed complete response to the addition of XELOX+bevacizumab therapy to preoperative chemoradiotherapy with S-1/CPT-11].
    Takahashi T; Namiki K; Matsumoto H; Konno F; Mitsui K; Yoshida R
    Gan To Kagaku Ryoho; 2014 May; 41(5):653-5. PubMed ID: 24917016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of advanced rectal cancer with bladder carcinoma salvaged from myocardial infarction during operation, showing tumor regression by XELOX treatment, good quality of life].
    Okumura K; Tani S; Shiogai Y; Kodama M; Mekata E; Tani T
    Gan To Kagaku Ryoho; 2013 Jan; 40(1):111-3. PubMed ID: 23306931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological complete response after neoadjuvant XELOX in advanced gastric carcinoma.
    Zhao Q; Li Y; Tian Y; Chen YN; Tan BB; Zhao XF; Jiao ZK; Zhang ZD; Chang SL
    Hepatogastroenterology; 2013 May; 60(123):638-40. PubMed ID: 23340232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case of Concurrent Cancer in a Giant Rectal Villous Adenoma That Resulted in Extensive Lymph Node Metastases].
    Ohtsuka M; Hata T; Hiraki M; Takeyama H; Nonaka R; Uemura M; Nishimura J; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2015 Jun; 42(6):747-50. PubMed ID: 26199250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.
    Chua YJ; Barbachano Y; Cunningham D; Oates JR; Brown G; Wotherspoon A; Tait D; Massey A; Tebbutt NC; Chau I
    Lancet Oncol; 2010 Mar; 11(3):241-8. PubMed ID: 20106720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.